Medical Oncology · Acibadem Kayseri Hospital Prof. Abdullah Büyükçelik, MD
✓ Medically verified profileProf. Abdullah Büyükçelik, MD
Prof. Abdullah Büyükçelik, MD is a medical oncologist at Acibadem Kayseri Hospital in Kayseri, Turkey. He treats lung and thoracic cancers, breast cancer, colorectal cancer, kidney cancer, ovarian and endometrial cancers, brain tumors, head and neck cancers and anal cancer. He speaks Turkish and English, and video consultation is available for international patients.
Accepting international patientsAbout Prof. Abdullah Büyükçelik, MD
Prof. Abdullah Büyükçelik, MD is a medical oncologist at Acibadem Kayseri Hospital in Kayseri, where he works in the Medical Oncology Department. He has more than 42 years in medicine. His clinical work is centered on the medical (drug-based) treatment of solid tumors, including cancers of the lung and chest, breast, colon and rectum, kidney, ovary, endometrium, brain, head and neck, and anal canal.
Dr. Büyükçelik studied medicine at İstanbul University İstanbul Faculty of Medicine from 1984 to 1990. He completed his Internal Medicine training at Ankara University Faculty of Medicine in 1996 and then worked as an Internal Medicine Specialist at Ankara Sevgi Hospital from 1996 to 1999. He returned to Ankara University Faculty of Medicine for his Medical Oncology specialization between 1999 and 2001, and remained in the Department of Medical Oncology from 2001 to 2009, including a period in the Bone Marrow Transplantation Unit from 2007 to 2009. He was appointed Associate Professor at Ankara University Faculty of Medicine in 2006 and has worked within Acıbadem Healthcare Services since 2009. He is a member of the Febril Nötropeni Association, the Medical Oncology Group, the Internal Medicine Association, the Medical Oncology Association and the Ankara Medical Oncology Association. His co-authored publications include studies on gastric adenocarcinoma, advanced pancreatic cancer, sarcomas and aggressive non-Hodgkin lymphoma, published in journals such as Tumori, European Journal of Cancer Care, Journal of Surgical Oncology and Medical Oncology.
Clinical focus
Dr. Büyükçelik treats patients with lung and thoracic cancers, breast cancer, including male breast cancer, and colorectal cancers, covering both colon cancer and rectal cancer. His practice also includes kidney cancer, anal cancer and head and neck cancers.
In gynecologic oncology he sees patients with ovarian cancer and endometrial cancer, and he is also involved in the medical management of patients with brain tumors. As a medical oncologist, his role generally concerns systemic treatment and follow-up, discussed alongside the other specialties involved in a patient’s care.
How Dr. Büyükçelik works with international patients
Dr. Büyükçelik speaks Turkish and English, and interpreters can be arranged for other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their case before or instead of traveling.
What Dr. Büyükçelik treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
Education, career and memberships
Education & training
Education
- 2006Ankara University Faculty of Medicine / Associate Professor
- 2001Ankara University Faculty of Medicine Medical Oncology
- 1996Ankara University Faculty of Medicine Internal Medicine
- 1984–1990İstanbul University İstanbul Faculty of Medicine
Career
Professional Experience
- 2009Acıbadem Healthcare Services
- 2007–2009Ankara University Faculty of Medicine Department of Medical Oncology / Bone Marrow Transplantation Unit
- 2001–2009Ankara University Faculty of Medicine, Department of Medical Oncology
- 1999–2001Ankara University Faculty of Medicine, Medical Oncology Specialization
- 1996–1999Ankara Sevgi Hospital / Internal Medicine Specialist
Memberships
Professional Memberships
- Febril Nötropeni Association
- Medical Oncology Group
- Internal Medicine Association
- Medical Oncology Association
- Ankara Medical Oncology Association
Selected publications
Selected Publications
- No abstract available. Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting? Med Hypotheses, 73, 628-629, (2009) Dogan M, Yalcin B, Ozal FG, Buyukcelik A, Utkan G, Icli F, Dogan L.
- Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Med Oncol, 2009 Sep 29 Dincol D, Buyukcelik A, Dogan M, Akbulut H, Samur M, Demirkazik A, Senler FC, Onur H, Icli F.
- Prognostic significance of serum matrix metalloproteinase 9 (MMP-9) levels in patients with sarcomas. Yaman E, Yalcin B, Utkan G, Akbulut H, Isikdogan A, Sencan O, Buyukcelik A, Demirkazik A, Icli F. UHOD, 18, 79-84, (2008)
- The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma. Şencan O, Buyukcelik A, Yalcin B, Boruban M.C, Akbulut H, Demirkazik A, Senler F.C, Onur H, Icli F. Eur J Cancer Care, 17,26-32, (2008)
- Lung cancer metastasis mimicking gluteal abscess. South Med. J, 100, 334-335, (2007) Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A.
- Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Buyukcelik A. J. Surg. Oncol, 95, 507-512, (2007)
- Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. South. Med. J. 99, 1149-1150, (2006) Utkan G, Buyukcelik A, Yalcin B, Tek I, Doruk H, Dincol D, Erekul S, Baykara M.
- Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin. Buyukcelik A, Onur H, Akbulut H, Bulent Y, Ensari A, Utkan G, Onal BS, Icli F. Tumori, 91, 302-308, (2005)
